| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ic14 | monocyte differentiation antigen cd14 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Sepsis[MeSHID:D018805] |
95.48 | phase 2 | inhibitor |
| ic14 | monocyte differentiation antigen cd14 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Sepsis[MeSHID:D018805] |
95.48 | phase 2 | unknown |
| ic14 | monocyte differentiation antigen cd14 | NA | Clinical trial target | TTD , DGIDB | Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
95.48 | phase 2 | unknown |
| ic14 | monocyte differentiation antigen cd14 | NA | Clinical trial target | TTD , DGIDB | Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
95.48 | phase 2 | inhibitor |
| click here to return to the previous page | ||||||||